Stamatios G. Gregoriou

Athens, ESYE31, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 139 publications

Prevalence of Regulatory Safety Risk Factors Among Adolescents and Adults With Atopic Dermatitis Receiving Advanced Systemic Therapies: An International Real-World Study.

Prevalence of Regulatory Safety Risk Factors Among Adolescents and Adults With Atopic Dermatitis Receiving Advanced Systemic Therapies: An International Real-World Study.

Journal: International journal of dermatology

Published: July 02, 2026

Letter: Nickel Sensitization After Patent Foramen Ovale Closure.

Letter: Nickel Sensitization After Patent Foramen Ovale Closure.

Journal: Dermatitis : contact, atopic, occupational, drug

Published: June 23, 2026

Sustained Minimal Disease Activity With Upadacitinib and Abrocitinib in Moderate-to-Severe Atopic Dermatitis: A 104-Week, Real-World, Retrospective Study.

Sustained Minimal Disease Activity With Upadacitinib and Abrocitinib in Moderate-to-Severe Atopic Dermatitis: A 104-Week, Real-World, Retrospective Study.

Journal: International journal of dermatology

Published: May 10, 2026

Position Statement of the EADV Task Forces With External Experts on Quality of Life Measurement in Hidradenitis Suppurativa: An Update.

Position Statement of the EADV Task Forces With External Experts on Quality of Life Measurement in Hidradenitis Suppurativa: An Update.

Journal: International journal of dermatology

Published: March 13, 2026

The Impact of Chronic Hand Eczema on Work Productivity and Quality of Life: A Cross-Sectional Study.

The Impact of Chronic Hand Eczema on Work Productivity and Quality of Life: A Cross-Sectional Study.

Journal: International journal of dermatology

Published: February 09, 2026

The definition of response and inadequate response to topical corticosteroid treatment in atopic dermatitis and related skin inflammatory diseases: A GA2LEN ADCARE statement paper.

The definition of response and inadequate response to topical corticosteroid treatment in atopic dermatitis and related skin inflammatory diseases: A GA2LEN ADCARE statement paper.

Journal: The World Allergy Organization journal

Published: January 28, 2026

Long-Term Effectiveness and Safety of Abrocitinib in Patients with Atopic Dermatitis: A Real-World, Retrospective Study.

Long-Term Effectiveness and Safety of Abrocitinib in Patients with Atopic Dermatitis: A Real-World, Retrospective Study.

Journal: Dermatology and therapy

Published: January 06, 2026

Refractory Dermatophytosis and Oral Hairy Leukoplakia as Sentinel Manifestations of Advanced HIV Infection.

Refractory Dermatophytosis and Oral Hairy Leukoplakia as Sentinel Manifestations of Advanced HIV Infection.

Journal: Cureus

Published: December 16, 2025

Clinical Trial Eligibility in Atopic Dermatitis: Data from a Large Real-World International Cohort.

Clinical Trial Eligibility in Atopic Dermatitis: Data from a Large Real-World International Cohort.

Journal: Dermatology and therapy

Published: November 14, 2025

Performance of omalizumab in patients with mast cell-mediated angioedema with and without wheals.

Performance of omalizumab in patients with mast cell-mediated angioedema with and without wheals.

Journal: The journal of allergy and clinical immunology. In practice

Published: November 06, 2025

Management of Patients with Nickel Hypersensitivity Undergoing Patent Foramen Ovale Closure.

Management of Patients with Nickel Hypersensitivity Undergoing Patent Foramen Ovale Closure.

Journal: Journal of clinical medicine

Published: September 17, 2025

Sex-Specific Differences in Patients With and Without Nickel Hypersensitivity Undergoing Patent Foramen Ovale Closure.

Sex-Specific Differences in Patients With and Without Nickel Hypersensitivity Undergoing Patent Foramen Ovale Closure.

Journal: JACC. Advances

Published: August 11, 2025

Showing 1-12 of 139

Last Updated: 09/26/2026